International Market Access Consulting (IMAC), consists of a global team of passionate individuals with decades of industry and consulting experience. Our team provides custom, high-impact, market access strategies and specialized, evidence‑based tools to effectively communicate the value of your product to key stakeholders in the payer landscape. As a specialist market access consulting company with a proven track record of success, we possess a high level of technical and scientific expertise to help our clients achieve their goals of optimized patient access for their products.
Fran Brown
Fran holds a PhD from the University of Leeds, funded through a BBSRC-Mondelēz collaboration, as well as a Master of Public Health from the University of Bristol. Since transitioning into market access consulting in 2023, she has supported HTA submissions and evidence development projects across Australia, New Zealand, and Canada. Fran specializes in evidence synthesis, reimbursement strategy, and market access support, with experience across a range of therapeutic areas.